Gene Editing Five Alarm Bio, Focused on Minimising the Effects of Aging in Humans, Raises Seed Investment Posted on February 28, 2023 by Editorial Staff Investors include Cambridge Angels, Meltwind, o2h Ventures, SyndicateRoom, and Angel investors, with support from KPMG Acceleris. Share on FacebookTweetFollow us Editorial Staff CN Bio extends microphysiological system portfolio with PhysioMimix Single-Organ Higher Throughput System Opinion: FDA needs to build in more flexibility for rare disease clinical trials
